337 related articles for article (PubMed ID: 32886418)
21. Effect of Sentinel Lymph Node Biopsy and LVI on Merkel Cell Carcinoma Prognosis and Treatment.
Harounian JA; Molin N; Galloway TJ; Ridge D; Bauman J; Farma J; Reddy S; Lango MN
Laryngoscope; 2021 Mar; 131(3):E828-E835. PubMed ID: 32663337
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Significance of Primary Tumor-Infiltrating Lymphocytes in a Contemporary Melanoma Cohort.
Straker RJ; Krupp K; Sharon CE; Thaler AS; Kelly NJ; Chu EY; Elder DE; Xu X; Miura JT; Karakousis GC
Ann Surg Oncol; 2022 Aug; 29(8):5207-5216. PubMed ID: 35301610
[TBL] [Abstract][Full Text] [Related]
23. Implication of IL6-positive Cancer-associated Fibroblasts in Merkel Cell Carcinoma Pathogenesis: A Possible Modulator of Immune Microenvironment.
Zheng Z; Yoo DS; Li S; Pei M; Lee SG; Kim JY; Chung KY; Roh MR
Anticancer Res; 2022 Sep; 42(9):4359-4369. PubMed ID: 36039447
[TBL] [Abstract][Full Text] [Related]
24. A Retrospective, Observational Analysis of Tumor Infiltrating Lymphocytes and Tumor Regression in Melanoma.
Zaladonis A; Farma J; Hill M; Hotz M; Meller K; Board T; Deng M; Wu H; Reddy S; O'Halloran E
J Surg Res; 2021 Nov; 267():203-208. PubMed ID: 34153563
[TBL] [Abstract][Full Text] [Related]
25. The value of tumor infiltrating lymphocytes as prognostic factor for lymph node status and survival amongst patients with cutaneous malignant melanoma.
Alexandru Gata V; Milan Kubelac P; Buiga R; Vlad IC; Valean D; Muntean MV; Morariu DS; Bonci EA; Irimie A; Dina C; Achimas Cadariu PA
J BUON; 2020; 25(6):2700-2707. PubMed ID: 33455116
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma.
Clemente CG; Mihm MC; Bufalino R; Zurrida S; Collini P; Cascinelli N
Cancer; 1996 Apr; 77(7):1303-10. PubMed ID: 8608507
[TBL] [Abstract][Full Text] [Related]
27. Lymph node ratio predicts efficacy of postoperative radiation therapy in nonmetastatic Merkel cell carcinoma: A population-based analysis.
Lamberti G; Andrini E; Siepe G; Mosconi C; Ambrosini V; Ricci C; Marchese PV; Ricco G; Casadei R; Campana D
Cancer Med; 2022 Nov; 11(22):4204-4213. PubMed ID: 35485165
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological characteristics and prognosis of Merkel cell carcinoma: a single-center retrospective study in Korea.
Moon IJ; Na H; Cho HS; Won CH; Chang SE; Lee MW; Lee WJ
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10065-10074. PubMed ID: 37261524
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Impact of MCPyV and TIL Subtyping in Merkel Cell Carcinoma: Evidence from a Large European Cohort of 95 Patients.
Ricci C; Righi A; Ambrosi F; Gibertoni D; Maletta F; Uccella S; Sessa F; Asioli S; Pellilli M; Maragliano R; La Rosa S; Papotti MG; Asioli S
Endocr Pathol; 2020 Mar; 31(1):21-32. PubMed ID: 31808008
[TBL] [Abstract][Full Text] [Related]
30. Diffuse distribution of tumor-infiltrating lymphocytes is a marker for better prognosis and chemotherapeutic effect in triple-negative breast cancer.
Hida AI; Watanabe T; Sagara Y; Kashiwaba M; Sagara Y; Aogi K; Ohi Y; Tanimoto A
Breast Cancer Res Treat; 2019 Nov; 178(2):283-294. PubMed ID: 31402409
[TBL] [Abstract][Full Text] [Related]
31. Merkel cell carcinoma: identification of prognostic factors unique to tumors located in the head and neck based on analysis of SEER data.
Smith VA; Camp ER; Lentsch EJ
Laryngoscope; 2012 Jun; 122(6):1283-90. PubMed ID: 22522673
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of tumor infiltrating lymphocytes in melanoma.
Burton AL; Roach BA; Mays MP; Chen AF; Ginter BA; Vierling AM; Scoggins CR; Martin RC; Stromberg AJ; Hagendoorn L; McMasters KM
Am Surg; 2011 Feb; 77(2):188-92. PubMed ID: 21337878
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis.
Gao G; Wang Z; Qu X; Zhang Z
BMC Cancer; 2020 Mar; 20(1):179. PubMed ID: 32131780
[TBL] [Abstract][Full Text] [Related]
34. Association Between Surgical Margins Larger Than 1 cm and Overall Survival in Patients With Merkel Cell Carcinoma.
Andruska N; Fischer-Valuck BW; Mahapatra L; Brenneman RJ; Gay HA; Thorstad WL; Fields RC; MacArthur KM; Baumann BC
JAMA Dermatol; 2021 May; 157(5):540-548. PubMed ID: 33760021
[TBL] [Abstract][Full Text] [Related]
35. Absolute lymphocyte count: a potential prognostic factor for Merkel cell carcinoma.
Johnson ME; Zhu F; Li T; Wu H; Galloway TJ; Farma JM; Perlis CS; Turaka A
J Am Acad Dermatol; 2014 Jun; 70(6):1028-35. PubMed ID: 24666998
[TBL] [Abstract][Full Text] [Related]
36. Complete spontaneous regression of primary Merkel cell carcinoma with tumoural infiltration: a systematic review.
Ah-Thiane L; Samimi M; Kervarrec T; Khammari A; Dréno B
Eur J Dermatol; 2021 Jun; 31(3):381-391. PubMed ID: 34080974
[TBL] [Abstract][Full Text] [Related]
37. No difference in survival for primary cutaneous Merkel cell carcinoma after Mohs micrographic surgery and wide local excision.
Moore KJ; Thakuria M; Ruiz ES
J Am Acad Dermatol; 2023 Aug; 89(2):254-260. PubMed ID: 37121483
[TBL] [Abstract][Full Text] [Related]
38. Intratumoral T-Lymphocyte Subsets in Canine Oral Melanoma and Their Association With Clinical and Histopathological Parameters.
Yasumaru CC; Xavier JG; Strefezzi RF; Salles-Gomes COM
Vet Pathol; 2021 May; 58(3):491-502. PubMed ID: 33764216
[TBL] [Abstract][Full Text] [Related]
39. Tumor-infiltrating lymphocytes are significantly associated with better overall survival and disease-free survival in triple-negative but not estrogen receptor-positive breast cancers.
Krishnamurti U; Wetherilt CS; Yang J; Peng L; Li X
Hum Pathol; 2017 Jun; 64():7-12. PubMed ID: 28153508
[TBL] [Abstract][Full Text] [Related]
40. Merkel cell carcinoma: high recurrence rate despite aggressive treatment.
Soult MC; Feliberti EC; Silverberg ML; Perry RR
J Surg Res; 2012 Sep; 177(1):75-80. PubMed ID: 22537840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
